Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001171843-15-002559
Filing Date
2015-05-06
Accepted
2015-05-06 15:43:16
Documents
1
Period of Report
2015-05-04

Document Format Files

Seq Description Document Type Size
1 formfour.html 4  
1 formfour.xml 4 4194
  Complete submission text file 0001171843-15-002559.txt   5526
Mailing Address C/O GENENTECH INC 1 DNA WAY MS 49 SOUTH SAN FRANCISCO CA 94080-4990
Business Address
SCHELLER RICHARD H (Reporting) CIK: 0001214133 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36687 | Film No.: 15836761

Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Issuer) CIK: 0001582313 (see all company filings)

EIN.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations